Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations - Wikidata - awgldk - TriplyDB

Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations

Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations

http://www.wikidata.org/entity/Q28140191

about

Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.Defining the borders of splenic marginal zone lymphoma: a multiparameter study.Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors.Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis.Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4 Cell kinetics and cell cycle regulation in lymphomas.Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer.CDK4: A Key Player in the Cell Cycle, Development, and Cancer Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.A new class of cyclin dependent kinase in Chlamydomonas is required for coupling cell size to cell division.Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.Cell cycle proteins as promising targets in cancer therapy Splenic marginal-zone lymphoma: ontogeny and genetics.Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression.Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma.Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

P2860

Q24312766-8D21E2EA-4634-4B1B-9E9D-8729AAEFDB64 Q24318430-2FD1347A-E69E-4697-AA10-BC12D73685FC Q24536146-49017E86-6AD2-441A-BD72-3980E9F4D6F6 Q26827580-8AA316CD-91DC-4139-BA42-BBAF33C6E336 Q28486949-A717B182-57CC-41DC-B050-D4A856970DED Q32180070-9DC1241C-E2C0-4B37-82B3-11552A1F7176 Q33890663-5ECF34F3-20A0-4734-B440-15AC0D6E0A6C Q33925119-A58E4690-37BC-4169-B057-FC23A0167476 Q33939203-CD484202-F984-4F9B-B5C3-D3C8CCB71633 Q33947132-3D6474D5-C3A8-4B85-91C1-D2C1B01DAE41 Q34078091-F7CB5C7B-3475-46B6-BBDB-8B6B743B3628 Q34310186-BC6DE055-7489-49A7-B850-DC095EE9974C Q34711793-A14383D7-6730-4649-BADE-6A81F244AF88 Q34768082-39B24384-4A59-4708-88B7-20E433C39593 Q34795916-B0E3E748-8F39-4859-95CD-F96F75F07637 Q35747628-6A6C2223-CDD3-46FA-8E7E-665484A3E529 Q35749003-58EF52B5-9D25-4254-87CA-FF7F19BD8565 Q35842194-27D0ECC8-A6C3-44FD-9DCD-C6FED10D5EFE Q36448676-72E173A5-DD0B-4E18-A393-25B9CC16A421 Q36796424-527EDDF8-685D-4F9B-8887-D949D2634E85 Q36824956-7F15FE1C-94DF-4ED4-B7AA-81309E81EA01 Q36827573-D074806E-5D9E-4AFD-B9A9-6EB23CA7A77C Q36982125-F0F33CA8-F64E-470C-A57E-071F9C2C42F1 Q37037268-4C17951D-4A93-4ED9-9A73-96F5011C1223 Q37171576-BE4916DF-BF6C-4B52-9797-9F40647E7984 Q37275203-14E3E67C-7825-43E6-BED0-0F667EEC6998 Q37693690-3B3B435E-4779-4FD8-B8CA-CCA75A8534A4 Q38209575-34DC1E92-DC7B-44E3-AC77-D3CA7D9DAC3F Q38458081-A4A31DDA-7923-4124-9884-2976ADD97E0A Q38742012-26984FFF-D2DF-4AF6-905E-A3FED5F6F9D7 Q38819164-5CC768E6-80AC-4C7B-8630-04840C7C3053 Q39311207-AB32B7FD-84AA-4108-8324-103E0C83328E Q40054898-681342CD-17E7-43B4-B287-EAF2C0F3D25B Q40558850-C3AC4C8C-E774-4478-9ECF-42095BAF0976 Q40656487-9ACC1A30-0334-43C5-ACFE-7B1B6AF67392 Q40775832-B9C2A58F-9EE8-4F9A-8155-B34DD575CC41 Q42390771-B9BE824B-7C03-4DE5-84BF-90F675E75E09 Q44319784-92E030C2-5701-41F8-8AEB-778E8B540108 Q47215137-B907B2E1-A8E4-4A9C-A9E5-0F433E69FE84

P2860

Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations

http://www.wikidata.org/entity/Q28140191

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@ast

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@en

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@nl

type

label

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@ast

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@en

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@nl

prefLabel

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@ast

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@en

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@nl

P1433

Q28140191-C71E799D-0C27-476C-8EA8-B49D8B715E21

P1476

Q28140191-73A92677-7EBB-4787-BF51-CF39B1D3D6B4

P2093

Q28140191-1B240AC5-6AC5-49D1-82B8-0FCA7BAD8119

Q28140191-2ED44DF9-B4EF-4CFA-AE8D-074035F156ED

Q28140191-509B6E3D-62D3-47AC-B901-B869F05F926B

Q28140191-6CB9ACD2-5CE1-4842-897B-4765D486A57D

Q28140191-78B3ED3E-0CD5-4F0A-810C-C08A3BDFD061

Q28140191-81A956A0-FB91-48C1-A090-E10694C136E0

Q28140191-A052200A-984B-495C-A610-B395B86A24E8

Q28140191-A442C0CA-E14C-4254-BED1-FB8885410060

Q28140191-A9AC32FF-6DD4-48B6-B88A-91C22F54A772

P2860

Q28140191-0213ECA9-695C-486E-8963-098C9B9BD92B

Q28140191-208D275F-AF90-4137-A902-B48F6E595DFF

Q28140191-303C87FB-62D8-4606-AC07-68F03B1F6347

Q28140191-42786323-7EE5-4E59-A8B9-8AD6961553B6

Q28140191-516E1E6D-2284-4769-8E6F-AADA09062743

Q28140191-66E53AA7-C105-448F-B61E-6CE3115F0AD7

Q28140191-6D90FF59-3B9E-44EC-8294-E53DEBD04A1F

Q28140191-76DD6D7C-AD69-4A9A-9920-FCC7699B0F3A

Q28140191-9026420A-2B8D-42B1-B7D6-E2556E8FEF76

Q28140191-970C912F-D090-4590-87DF-DDCDAE4F6451

P2888

Q28140191-46E4012A-9127-402F-8C2F-F621E6930F1A

P304

Q28140191-03D424BF-EC69-413F-9D49-924B2D28779B

P31

Q28140191-87A95F37-E6DB-4772-B196-89FB639138CB

P3181

Q28140191-FF6FF8C2-8D6C-49E8-BD08-D11D1188E39B

P356

Q28140191-F97C41DF-07E9-4062-94BA-E20B128A5D3F

P407

Q28140191-CF7A53A6-3047-4129-9585-CCBBAA0FF702

P433

Q28140191-449DAD4C-79FC-4479-9103-DE223F6463B9

P478

Q28140191-57464407-CEFB-4F5E-81EF-84A6FD3C8B34

P50

Q28140191-BA9AAA4E-3A09-4353-BF9E-756B29CFA702

P577

Q28140191-9CB06E5C-F480-4B23-8B23-30B44E7F6984

P5875

Q28140191-7CC6EE1D-2F09-4B5F-9163-F226B5966EE7

P6179

Q28140191-829525EA-4F5B-4CC0-9D3D-FFB4ECAEA981

P698

Q28140191-3AB33224-02AE-4BF6-9ADC-F81A92CE538C

P3181

P356

P1433

P1476

Dysregulation of cyclin depend ...... h chromosome 7q translocations

@en

P2093

A P Boright

http://www.w3.org/2001/XMLSchema#string

C Platt

http://www.w3.org/2001/XMLSchema#string

D G Oscier

http://www.w3.org/2001/XMLSchema#string

J A Orchard

http://www.w3.org/2001/XMLSchema#string

L C Tsui

http://www.w3.org/2001/XMLSchema#string

M M Corcoran

http://www.w3.org/2001/XMLSchema#string

R E Ibbotson

http://www.w3.org/2001/XMLSchema#string

R M Chapman

http://www.w3.org/2001/XMLSchema#string

S J Mould

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

The XRCC2 DNA repair gene: identification of a positional candidate

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Regulation of CAK kinase activity by p53

Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms

Refined localization of the asparagine synthetase gene (ASNS) to chromosome 7, region q21.3, and characterization of the somatic cell hybrid line 4AF/106/KO15.

Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes.

Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site.

Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases

Regional localization of 725 human chromosome 7-specific yeast artificial chromosome clones.

P2888

P304

6271-6277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5054822

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1203033

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Stephen W. Scherer

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12704640

http://www.w3.org/2001/XMLSchema#string

P6179

1005680178

http://www.w3.org/2001/XMLSchema#string

P698

10597225

http://www.w3.org/2001/XMLSchema#string